PART I . Overview We are a technology-based company with a well-established laboratory services business and a therapeutic development business. Our laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Our therapeutic development business is focused on developing product candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to ...
expected 2026-10-29
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001193125-26-079169 | EDGAR | 109K words |
| 2025-02-28 | 2024-12-31 | 0000950170-25-029512 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000950170-24-022233 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005178 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007366 | EDGAR | — |
| 2021-03-08 | 2020-12-31 | 0001564590-21-011526 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001564590-20-010617 | EDGAR | — |
| 2019-03-22 | 2018-12-31 | 0001564590-19-008991 | EDGAR | — |
| 2018-03-20 | 2017-12-31 | 0001564590-18-006239 | EDGAR | — |
| 2017-03-17 | 2016-12-31 | 0001564590-17-004681 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001193125-26-326136 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001193125-25-271013 | EDGAR | 30K words |
| 2025-08-01 | 2025-06-30 | 0000950170-25-101105 | EDGAR | — |
| 2025-05-02 | 2025-03-31 | 0000950170-25-062258 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000950170-24-123684 | EDGAR | — |
| 2024-08-02 | 2024-06-30 | 0000950170-24-089592 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0000950170-24-052485 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000950170-23-058512 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000950170-23-038316 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0000950170-23-018079 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022661 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014856 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0001193125-26-326119 | EDGAR | — |
| 2026-03-17 | 0001674930-26-000012 | EDGAR | 2K words |
| 2026-02-27 | 0001193125-26-079152 | EDGAR | — |
| 2025-12-22 | 0001193125-25-328747 | EDGAR | — |
| 2025-11-07 | 0001193125-25-271006 | EDGAR | — |
| 2025-10-20 | 0001193125-25-242917 | EDGAR | — |
| 2025-08-01 | 0000950170-25-101103 | EDGAR | — |
| 2025-05-15 | 0000950170-25-072676 | EDGAR | — |
| 2025-05-02 | 0000950170-25-062257 | EDGAR | — |
| 2025-02-28 | 0000950170-25-029510 | EDGAR | — |
137 total filings indexed. 105 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001674930 |
| Ticker | FLGT |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
| Website | https://www.fulgentgenetics.com |
| Listed | 2016-09-29 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/FLGT (~200 tokens, structured JSON with cryptographic provenance)